Skip to main navigation
Supernus Pharmaceuticals

Header Links

  • Return to Supernus.com

Investor Relations

  • Overview
  • News & Events
    Press Releases Events & Presentations
  • Governance
    Corporate Governance Management Board of Directors Committee Composition Contact the Board
  • Financials & Filings
    Financials & Filings SEC Filings Annuals & Proxies Quarterly Results
  • Stock
    Stock Information Historic Stock Lookup Investment Calculator Ownership Profile
  • Contact Us

Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • Financials & Filings
    • SEC Filings
    • Annuals & Proxies
    • Quarterly Results
  • Stock
    • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Ownership Profile
  • Contact Us

    Breadcrumb

  1. Investor Relations
  2. Press Releases

Press Releases

Date Title  
May 27, 2026
Supernus Pharmaceuticals to Participate in June Investor Conferences
PDF Version
May 6, 2026
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
PDF Version
May 5, 2026
Supernus Announces First Quarter 2026 Financial Results
PDF Version
April 22, 2026
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
PDF Version
February 24, 2026
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
PDF Version
February 23, 2026
Supernus Pharmaceuticals to Participate in March Investor Conferences
PDF Version
February 12, 2026
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
PDF Version

Shareholder Tools


Email Alerts


RSS Feeds


Search

Back to Top
Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
Rockville, MD 20850
(301) 838-2500
info@supernus.com

Back to Top

© 2026 Supernus Pharmaceuticals

Post Footer Links

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • State Policy
  • Social Media Community Guidelines